Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer

NCT02438852 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No funding

Conditions

Bladder Carcinoma
Post-operative Pain

Interventions

OTHER: Placebo
OTHER: Questionnaire Administration
DRUG: Ropivacaine Hydrochloride

Sponsor

University of Southern California

Collaborators

[object Object]